A 3-year experience of quality control and quality assurance in the multisite delivery of a lymphocyte-based cellular therapy for renal cell carcinoma
- 5 April 1994
- journal article
- research article
- Published by Wiley in Biotechnology & Bioengineering
- Vol. 43 (8) , 693-699
- https://doi.org/10.1002/bit.260430804
Abstract
No abstract availableKeywords
This publication has 2 references indexed in Scilit:
- Regulatory Concerns in Human Gene TherapyHuman Gene Therapy, 1991
- Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinomaThe Lancet, 1990